Trials / Active Not Recruiting
Active Not RecruitingNCT07212426
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.
A Phase II, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria.
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Longbio Pharma · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, randomized, open-label, Phase II clinical study to evaluate the efficacy, safety, and pharmacokinetics of LP-005 injection in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | LP-005 Injection | IV infusion, Q4W |
Timeline
- Start date
- 2024-11-14
- Primary completion
- 2026-05-06
- Completion
- 2028-03-31
- First posted
- 2025-10-08
- Last updated
- 2026-01-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07212426. Inclusion in this directory is not an endorsement.